GEORGE F WOOTEN

Summary

Affiliation: University of Virginia
Country: USA

Publications

  1. ncbi The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study
    Jeanne C Latourelle
    Department of Neurology, Boston University School of Medicine, Boston University, Boston, MA, USA
    BMC Med 6:32. 2008
  2. ncbi Anatomy and function of dopamine receptors: understanding the pathophysiology of fluctuations in Parkinson's disease
    G F Wooten
    Department of Neurology, University of Virginia Health System, Box 800394, Charlottesville, VA 22908, USA
    Parkinsonism Relat Disord 8:79-83. 2001
  3. ncbi Are men at greater risk for Parkinson's disease than women?
    G F Wooten
    Department of Neurology, Box 800394, University Health System, University of Virginia School of Medicine, Charlottesville, VA 22908, USA
    J Neurol Neurosurg Psychiatry 75:637-9. 2004

Research Grants

  1. Parkinson's Disease Neuroprotection Clinical Trial
    GEORGE WOOTEN; Fiscal Year: 2007

Collaborators

  • Jae Lee
  • Jeanne C Latourelle
  • Michael W Nagle
  • Barry Snow
  • Jemma B Wilk
  • Franca Cambi
  • Mark Guttman
  • Sally Williamson
  • Richard H Myers
  • Alastair Corbett
  • Patrick F Chinnery
  • Marie H Saint-Hilaire
  • Oksana Suchowersky
  • Jason M Laramie
  • Richard Roxburgh
  • James F Gusella
  • Peter P Pramstaller
  • Michela Zini
  • Scott J Sherman
  • Kenneth B Baker
  • Edward Drasby
  • Stuart Isaacson
  • Irene Litvan
  • Martha Nance
  • Gianni Pezzoli
  • Carlos Singer
  • Karen W Huskey
  • Audrey E Hendricks
  • Ray L Watts
  • Mark F Lew
  • Garth Nicholson
  • Joel S Perlmutter
  • John H Growdon
  • Lawrence I Golbe
  • Tiffany Massood
  • Brad A Racette
  • Christine Klein
  • David J Burn
  • Anwar Ahmed
  • John T Slevin
  • Anette T Moller
  • Stefano Goldwurm
  • Jomana Al-Hinti
  • Holly A Shill
  • Karen Ostergaard
  • Anita L Destefano
  • Mei Sun
  • Ilia Itin
  • Margery H Mark

Detail Information

Publications3

  1. ncbi The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study
    Jeanne C Latourelle
    Department of Neurology, Boston University School of Medicine, Boston University, Boston, MA, USA
    BMC Med 6:32. 2008
    ..Studies of the penetrance of LRRK2 mutations have produced a wide range of estimates, possibly due to differences in study design and recruitment, including in particular differences between samples of familial PD versus sporadic PD...
  2. ncbi Anatomy and function of dopamine receptors: understanding the pathophysiology of fluctuations in Parkinson's disease
    G F Wooten
    Department of Neurology, University of Virginia Health System, Box 800394, Charlottesville, VA 22908, USA
    Parkinsonism Relat Disord 8:79-83. 2001
    ..These mechanisms result in excessive, pathological inhibition of basal ganglia output neurons in the GPi producing dyskinesias and the short duration response...
  3. ncbi Are men at greater risk for Parkinson's disease than women?
    G F Wooten
    Department of Neurology, Box 800394, University Health System, University of Virginia School of Medicine, Charlottesville, VA 22908, USA
    J Neurol Neurosurg Psychiatry 75:637-9. 2004
    ..5 times greater in men than women. Possible reasons for this increased risk of Parkinson's disease in men are toxicant exposure, head trauma, neuroprotection by oestrogen, mitochondrial dysfunction, or X linkage of genetic risk factors...

Research Grants3

  1. Parkinson's Disease Neuroprotection Clinical Trial
    GEORGE WOOTEN; Fiscal Year: 2007
    ..Our team is experienced, productive, and fully able to meet the requirements to become a Clinical Cente for the Parkinson's Disease Neuroprotection Trial. ..